Trade NVAX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Novavax, Inc. (NVAX) is trading at US$8.92, down 1.49% today as of Aug 28, 13:01 EDT. The company has a market capitalisation of US$1.47B. Over the past 52 weeks, NVAX has traded between US$6.20 and US$11.97. On Syfe you can trade NVAX with $0 commission and add it to your watchlist.
| Previous close | US$9.05 |
|---|---|
| Market cap | US$1.47B |
| 52-week range | US$6.20 – US$11.97 |
| Volume | 3.41M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Novavax, Inc.
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Year: 1995
Novavax Shares Rise After Narrower-Than-Expected Q1 Net Loss
May 6, 1:44 PM · MT Newswires
--Earnings Flash (NVAX) Novavax Posts Q1 Net Loss $0.06 a Share, vs. FactSet Est of $0.24 Loss
May 6, 12:02 PM · MT Newswires
Novavax, Inc. (NVAX) stock is trading at US$8.92, -1.49% from the previous close of US$9.05.
The market cap for Novavax, Inc. (NVAX) stock is approximately US$1.47B.
The 52-week high for Novavax, Inc. (NVAX) stock is US$11.97.
The 52-week low for Novavax, Inc. (NVAX) stock is US$6.20.
Novavax, Inc. (NVAX) does not currently pay a dividend.
Stay on top of NVAX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
